Kinsale Capital Reports Strong Q2 Profit Growth Despite Premium Decline, Boosts Share Buyback Program
KNSL sits 17% above its 52-week low of $287.2.
Summary
Kinsale Capital Group reported strong Q2 profit growth and an improved combined ratio, but gross written premiums declined due to competition; the company also authorized an additional $250 million for share repurchases and received a favorable legal update.
Key Events · Earnings and Guidance · KNSL
-
Strong Q2 Profitability
Net income increased 31.1% to $175.9 million for the three months ended June 30, 2026, compared to $134.1 million in the prior year. Diluted earnings per share rose to $7.72 from $5.76.
-
Improved Underwriting Performance
The combined ratio improved to 75.5% for Q2 2026, down from 75.8% in Q2 2025, reflecting continued underwriting profitability and favorable loss reserve development.
-
Gross Written Premiums Decline
Gross written premiums decreased 5.0% to $527.6 million in Q2 2026, primarily due to a 32.7% decline in the Commercial Property Division driven by heightened competition. Year-to-date gross written premiums also fell 2.9%.
-
Increased Share Repurchase Authorization
The Board authorized an additional $250.0 million for share repurchases in July 2026, bringing the total remaining capacity under the program to $337.5 million.
Analysis · KNSL · Finance
Kinsale Capital Group reported robust net income and EPS growth for Q2 and year-to-date 2026, driven by strong underwriting profitability and investment income. However, gross written premiums declined, notably in the Commercial Property Division, indicating competitive pressures on the top line. The company also announced a significant increase in its share repurchase authorization, signaling a strong commitment to returning capital to shareholders. A favorable update on a major legal proceeding further reduces a potential liability.
At the time of this filing, KNSL was trading at $336.00 on NYSE in the Finance sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $287.20 to $512.76. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.